Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Eastman Chemical (EMN) over the last 17 years, with Q4 2025 value amounting to $566.0 million.

  • Eastman Chemical's Cash & Equivalents fell 3237.75% to $566.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $566.0 million, marking a year-over-year decrease of 3237.75%. This contributed to the annual value of $566.0 million for FY2025, which is 3237.75% down from last year.
  • Latest data reveals that Eastman Chemical reported Cash & Equivalents of $566.0 million as of Q4 2025, which was down 3237.75% from $489.0 million recorded in Q3 2025.
  • In the past 5 years, Eastman Chemical's Cash & Equivalents registered a high of $837.0 million during Q4 2024, and its lowest value of $410.0 million during Q2 2023.
  • For the 5-year period, Eastman Chemical's Cash & Equivalents averaged around $529.3 million, with its median value being $496.0 million (2022).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 3570.43% in 2022, then skyrocketed by 5273.72% in 2024.
  • Over the past 5 years, Eastman Chemical's Cash & Equivalents (Quarter) stood at $459.0 million in 2021, then rose by 7.41% to $493.0 million in 2022, then grew by 11.16% to $548.0 million in 2023, then soared by 52.74% to $837.0 million in 2024, then tumbled by 32.38% to $566.0 million in 2025.
  • Its Cash & Equivalents was $566.0 million in Q4 2025, compared to $489.0 million in Q3 2025 and $423.0 million in Q2 2025.